liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
FFirst-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
Karolinska Inst, Sweden.
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Karolinska Inst, Sweden.
Skane Univ Hosp, Sweden; Lund Univ, Sweden.
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: Haematologica, ISSN 0390-6078, E-ISSN 1592-8721, Vol. 104, nr 4, s. 797-805Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

The aim of this study was to investigate long-term outcome following first-line therapy in consecutive chronic lymphocytic leukemia (CLL) patients in a well-defined geographic area: Sweden. All patients diagnosed with CLL (2007-2013) (n=3672) were identified from national registries, screening of patient files identified all (100%) treated first line (n=1053) and for those, an in-depth analysis was performed. End points were overall response rate, progression-free survival (PFS), overall survival (OS), and safety. Median age was 71 years; 53% had Rai stage III-IV and 97% had performance status grade 0-2. Fluorescence in situ hybridization (FISH) was performed in 57% of patients: 15% had del(17p). Chlorambucil + prednisone was used in 39% (5% also received rituximab). Fludarabine+cyclophosphamide+rituximab or fludarabine+cyclophosphamide was used in 43% and bendamustine + rituximab in 6%. Overall response rate was 64%; chlorambucil 43%, fludarabine+cyclophosphamide+rituximab 84%, fludarabine+cyclophosphamide 75% and bendamustine + rituximab 75%. Median PFS and OS was 24 and 58 months, respectively, both were significantly associated (multivariate analysis) with type of treatment, del(17p), performance status, gender, age and geographical region (OS only). Chlorambucil-treated patients had a median PFS and OS of only 9 and 33 months, respectively. Chlorambucil usage declined gradually throughout the study period, but one-third of patients still received chlorambucil + rituximab in 2013. Infections amp;gt;= grade III were significantly associated with treatment; chlorambucil 19% versus fludarabine+cyclophosphamide+rituximab 30%. Richter transformation occurred in 5.5% of the patients, equally distributed across therapies. This is the largest retrospective, real-world cohort of consecutive first-line treated CLL patients with a complete follow up. In elderly patients, an unmet need for more effective, well-tolerated therapies was identified.

Ort, förlag, år, upplaga, sidor
FERRATA STORTI FOUNDATION , 2019. Vol. 104, nr 4, s. 797-805
Nationell ämneskategori
Hematologi
Identifikatorer
URN: urn:nbn:se:liu:diva-156385DOI: 10.3324/haematol.2018.200204ISI: 000462841300036PubMedID: 30467205OAI: oai:DiVA.org:liu-156385DiVA, id: diva2:1305735
Anmärkning

Funding Agencies|AFA Insurance [130054]; SLL/ALF [20150070]; Blodcancerfonden 2016; Dr Ake Olsson Foundation [2-791/2016]; SLL/KI Hogre klinisk forskare 2018/2019 [K2894-2016]; Svenska Lakaresallskapet [SLS-406961]; Gilead Sciences Nordic Fellowship Programme 2015; Swedish Cancer Society [150930, 160534]

Tillgänglig från: 2019-04-18 Skapad: 2019-04-18 Senast uppdaterad: 2019-08-12

Open Access i DiVA

fulltext(1095 kB)38 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1095 kBChecksumma SHA-512
28a06c54fb7645a5520d78390867b3fc6e3531a746b9cbbeff953d541a254e11bc97034a1fcd539806d3dd2e7fd222af65623c98172eccdfc7f4e9a95d82e5c0
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Sandstedt, Anna
Av organisationen
Institutionen för samhälls- och välfärdsstudierHälsouniversitetetHematologiska kliniken US
I samma tidskrift
Haematologica
Hematologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 38 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 83 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf